References
- Schraffordt Koops H, Kroon B BR, Lejeune F J. Isolated regional perfusion in the treatment of local recurrence, satellites and in-transit metastases of extremity melanomas. Therapy of Advanced Melanoma. Pigment Cell, P Rümke. Karger, Basel 1990; vol 10: 67–78
- Kroon B BR. Regional isolation perfusion in melanoma of the limbs: accomplishments, unsolved problems, future. Eur J Surg Oncol. 1988; 14: 101–110
- Ghussen F, Kruger I. Technical aspects of isolation extremity perfusion: experimental studies and clinical experience. J Invest Surg. 1989; 2: 487–496
- Ghussen F, Nagel K, Groth W, Muller J M, Stutzer H. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg. 1984; 200: 764–768
- Krementz E T, Saha S. Limb perfusion with melphalan for melanoma by increased dose and dilution compared to standard technique: a pilot study. Reg Cancer Treat. 1989; 2: 233–237
- Matsen F A, Wyss C R, Pedegana L R, Krugmire R B, Simmons L W, King R V, Burgess E M. Transcutaneous oxygen tension measurement in peripheral vascular disease. Surg Oncol Obstet. 1980; 150: 525–528
- Fontijne W PJ, De Vries J, Mook P H, Elstradt J M, Oosterhen J W, Schraffordt, Koops H, Oldhoff J, Wildevuur L RH. Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion in dogs. J Surg Oncol. 1984; 26: 69–76
- Fontijne W PJ, Mook P H, Schraffordt, Koops H, Oldhoff J, Wildevuur ChRH. Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. Cancer 1985; 55: 1455–1461
- Byrne D S, McKay A J, Scott R N, Blockie R, Hughes J, Burnside G, Mackie R M. Assessment of regional perfusion for melanoma by perioperative transcutaneous oxygen tension measurement. Reg Cancer Treat. 1990; 3: 88–89
- Wieberdink J. Physiological Considerations Regurding Isolation Perfusion of the Extremities. Monograph available on request from The Netherlands Cancer Institute Amsterdam. Krips Repro Meppel, The Netherlands
- Wieberdink J, Benckhuijsen C, Braat R P, van Slooten E A, Olthuis G AA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic reactions. EurJ Cancer Clin Oncol. 1982; 18: 905–910
- Omlor G, Schellhase K P, Molter G, Menger M D, Motsch H, Walter P. Hemodynamics as indicators of flow rates during isolated limb perfusion. Reg Cancer Treat. 1990; 3: 103–106
- Benckhuijsen C, Varossieau F J, Hart A AM, Wieberdink J, Noordhoek J. Pharmacokinetics of melphalan in isolated perfusion of the limbs. J Pharmacol Exp Ther. 1985; 237: 583–588
- Human Physiology, RF Schmidt, G Thews. Springer-Verlag, Berlin, Heidelberg 1983
- Van der Zee J, Broekmeyer-Reurink M P, Van den Berg A P, van Geel A N, Jansen R FM, Kroon B BR, van Wijk Y, Hagenbeck A. Temperature Distribution and pH changes during hyperthermic regional isolation perfusion. Eur J Cancer Clin Oncol. 1989; 25: 1157–1163
- Van de Merwe S A, Van den Berg A P, Van den Berge A W, Klaase J M, Kroon B BR, Van der Zee J. Modification of human tissue pH during hyperthermic and normothermic regional isolation perfusion: a pilot study. Int J Hyperthermia. 1993; 9: 205–217
- Rutherford R B. Vascular Surgery. WB Saunders Company, Philadelphia 1989; vol I
- Klaase J M, Kroon B BR, van Geel A N, van Wijk J, Franklin H R, Eggermont A MM, Hart A AM. Prognostic factors, limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg. 1994, in press
- Klaase J M, Kroon B BR, van Slooten G W, Benckhuijsen C. Melphalan peak concentration and toxicity in regional isolated perfusion. Reg Cancer Treat. 1992; 4: 309–312
- Klaase J M, Kroon B BR, van Geel A N, Eggermont A MM, Franklin H R, Hart A AM. Patient and treatment related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities. Am J Surg. 1994, (in press)